Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|August 30, 2005
Mycobacterium smegmatis Erm(38) is a reluctant dimethyltransferaseChristian Toft Madsen, Lene Jakobsen, Stephen Douthwaite
Nucleic Acids Research|August 9, 2003
Identifying the methyltransferases for m(5)U747 and m(5)U1939 in 23S rRNA using MALDI mass spectrometryChristian Toft Madsen, Jonas Mengel-Jørgensen, Finn Kirpekar, et al.
Molecular Plant-Microbe Interactions : MPMI|November 6, 2007
Stability of Barley stripe mosaic virus-induced gene silencing in barleyMarianne Bruun-Rasmussen, Christian Toft Madsen, Stine Jessing, et al.
The Journal of Biological Chemistry|September 22, 2005
Methyltransferase Erm(37) slips on rRNA to confer atypical resistance in Mycobacterium tuberculosisChristian Toft Madsen, Lene Jakobsen, Karolina Buriánková, et al.
Bioinformatics (Oxford, England)|October 9, 2023
DeepPeptide predicts cleaved peptides in proteins using conditional random fieldsFelix Teufel, Jan Christian Refsgaard, Christian Toft Madsen, et al.
Biochimica Et Biophysica Acta|April 7, 2009
Identification and characterization of barley RNA-directed RNA polymerasesChristian Toft Madsen, Jennifer Stephens, Csaba Hornyik, et al.
American Heart Journal|June 7, 2011
Depressive symptoms and inflammation in patients hospitalized for heart failurePeter Johansson, Ivonne Lesman-Leegte, Erland Svensson, et al.
European Heart Journal|April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialStefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Journal of Cardiac Failure|November 14, 2020
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI TrialSteven R Goldsmith, Daniel Burkhoff, Finn Gustafsson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2026
Vessel-specific angiography-derived index of microcirculatory resistance in an all-comer population undergoing percutaneous coronary intervention, a PIONEER IV trial substudyChris Lenselink, Kim Ricken, Tsung-Ying Tsai, et al.
Pageof 5